United States Wound Closure Devices Market Outlook to 2020
Summary
GlobalData’s new report, "United States Wound Closure Devices Market Outlook to 2020", provides key market data on the United States Wound Closure Devices Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Hemostats (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based and Collagen Based Hemostats), Tissue Adhesives (Cyanoacrylate Based and Other Cross-linkable Polymer Based Tissue Adhesives), Tissue Sealants (Synthetic Tissue Sealants and Non-Synthetic Tissue Sealants (Fibrin Based Tissue Sealants (Fibrin Based Tissue Sealants in Liquid Form and in Patch Form), Collagen Based Tissue Sealants and Protein Based Tissue Sealants)), Ligating Clips (Titanium and Polymer Ligating Clips), Surgical Stapling Devices (Powered Surgical Stapling Devices (Reusable Powered and Disposable Powered Surgical Stapling Devices), Manual Surgical Stapling Devices (Reusable Manual and Disposable Manual Surgical Stapling Devices)), Surgical Adhesion Barriers (Membrane and Gel Adhesion Barriers) and Wound Closure Strips.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Wound Closure Devices market wherever available.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size data for Wound Closure Devices market segments - Hemostats, Tissue Adhesives, Tissue Sealants, Ligating Clips, Surgical Stapling Devices, Surgical Adhesion Barriers and Wound Closure Strips.
- Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
- 2013 company shares and distribution shares data for Wound Closure Devices market.
- Global corporate-level profiles of key companies operating within the United States Wound Closure Devices.
- Key players covered include Johnson & Johnson, Baxter International Inc. and Pfizer Inc.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Wound Closure Devices Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 11
3 Wound Closure Devices Market, United States 15
3.1 Wound Closure Devices Market, United States, Revenue ($m), 2005-2013 15
3.2 Wound Closure Devices Market, United States, Revenue ($m), 2013-2020 17
3.2.1 Hemostats Market, United States, Revenue ($m), by Segment, 2005-2013 19
3.2.2 Ligating Clips Market, United States, Revenue ($m), by Segment, 2005-2013 21
3.2.3 Surgical Adhesion Barriers Market, United States, Revenue ($m), by Segment, 2005-2013 23
3.2.4 Surgical Stapling Devices Market, United States, Revenue ($m), by Segment, 2005-2013 24
3.2.4.1 Manual Surgical Stapling Devices Market, United States, Revenue ($m), by Sub Segment, 2005-2013 26
3.2.4.2 Powered Surgical Stapling Devices Market, United States, Revenue ($m), by Sub Segment, 2005-2013 28
3.2.5 Tissue Adhesives Market, United States, Revenue ($m), by Segment, 2005-2013 30
3.2.6 Tissue Sealants Market, United States, Revenue ($m), by Segment, 2005-2013 32
3.2.6.1 Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), by Sub Segment, 2005-2013 34
3.2.6.1.1 Fibrin Based Tissue Sealants Market, United States, Revenue ($m), by Sub Segment, 2005-2013 36
3.2.7 Hemostats Market, United States, Revenue ($m), by Segment, 2013-2020 38
3.2.8 Ligating Clips Market, United States, Revenue ($m), by Segment, 2013-2020 40
3.2.9 Surgical Adhesion Barriers Market, United States, Revenue ($m), by Segment, 2013-2020 42
3.2.10 Surgical Stapling Devices Market, United States, Revenue ($m), by Segment, 2013-2020 44
3.2.10.1 Manual Surgical Stapling Devices Market, United States, Revenue ($m), by Sub Segment, 2013-2020 46
3.2.10.2 Powered Surgical Stapling Devices Market, United States, Revenue ($m), by Sub Segment, 2013-2020 48
3.2.11 Tissue Adhesives Market, United States, Revenue ($m), by Segment, 2013-2020 50
3.2.12 Tissue Sealants Market, United States, Revenue ($m), by Segment, 2013-2020 52
3.2.12.1 Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), by Sub Segment, 2013-2020 54
3.2.12.1.1 Fibrin Based Tissue Sealants Market, United States, Revenue ($m), by Sub Segment, 2013-2020 56
3.3 Wound Closure Devices Market, United States, Volume (Units), 2005-2013 58
3.4 Wound Closure Devices Market, United States, Volume (Units), 2013-2020 60
3.4.1 Hemostats Market, United States, Volume (Units), by Segment, 2005-2013 62
3.4.2 Ligating Clips Market, United States, Volume (Units), by Segment, 2005-2013 64
3.4.3 Surgical Adhesion Barriers Market, United States, Volume (Units), by Segment, 2005-2013 66
3.4.4 Surgical Stapling Devices Market, United States, Volume (Units), by Segment, 2005-2013 67
3.4.4.1 Manual Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, 2005-2013 69
3.4.4.2 Powered Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, 2005-2013 71
3.4.5 Tissue Adhesives Market, United States, Volume (Units), by Segment, 2005-2013 73
3.4.6 Tissue Sealants Market, United States, Volume (Units), by Segment, 2005-2013 75
3.4.6.1 Non-Synthetic Tissue Sealants Market, United States, Volume (Units), by Sub Segment, 2005-2013 77
3.4.6.1.1 Fibrin Based Tissue Sealants Market, United States, Volume (Units), by Sub Segment, 2005-2013 79
3.4.7 Hemostats Market, United States, Volume (Units), by Segment, 2013-2020 81
3.4.8 Ligating Clips Market, United States, Volume (Units), by Segment, 2013-2020 83
3.4.9 Surgical Adhesion Barriers Market, United States, Volume (Units), by Segment, 2013-2020 85
3.4.10 Surgical Stapling Devices Market, United States, Volume (Units), by Segment, 2013-2020 87
3.4.10.1 Manual Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, 2013-2020 89
3.4.10.2 Powered Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, 2013-2020 91
3.4.11 Tissue Adhesives Market, United States, Volume (Units), by Segment, 2013-2020 93
3.4.12 Tissue Sealants Market, United States, Volume (Units), by Segment, 2013-2020 95
3.4.12.1 Non-Synthetic Tissue Sealants Market, United States, Volume (Units), by Sub Segment, 2013-2020 97
3.4.12.1.1 Fibrin Based Tissue Sealants Market, United States, Volume (Units), by Sub Segment, 2013-2020 99
3.5 Wound Closure Devices Market, United States, Average Price ($), 2005-2020 101
3.6 Wound Closure Devices Market, United States, Distribution Share by Revenue ($m), 2012-2013 105
3.7 Wound Closure Devices Market, United States, Company Share by Revenue ($m), 2012-2013 106
4 Overview of Key Companies in United States, Wound Closure Devices Market 108
4.1 Johnson & Johnson 108
4.1.1 Company Overview 108
4.2 Covidien plc 108
4.2.1 Company Overview 108
4.3 Baxter International Inc. 108
4.3.1 Company Overview 108
4.4 Pfizer Inc. 109
4.4.1 Company Overview 109
4.5 3M Health Care Ltd 109
4.5.1 Company Overview 109
4.6 Genzyme Corporation 109
4.6.1 Company Overview 109
4.7 Teleflex Incorporated 110
4.7.1 Company Overview 110
4.8 B. Braun Melsungen AG 110
4.8.1 Company Overview 110
5 Wound Closure Devices Market Pipeline Products 111
6 Financial Deals Landscape 112
6.1 Equity Offerings 112
6.1.1 Derma Sciences Completes Public Offering Of Shares For US$86.3 Million 112
6.1.2 SafeStitch Medical Completes Private Placement Of Shares And Warrants For US$3 Million 114
6.2 Venture Financing 115
6.2.1 BioDerm to Raise USD4.8 Million in Venture Financing 115
6.2.2 Surgimatix To Raise US$0.5 Million In Venture Financing 116
6.2.3 MxBiodevices To Raise US$8 Million In Venture Financing 117
6.2.4 MxBiodevices Raises US$0.2 Million In Venture Financing 118
7 Recent Developments 119
7.1 Corporate Communications 119
7.1.1 Apr 07, 2014: Cytomedix Announces Appointment of Andrew Cohen as Vice President of Marketing 119
7.1.2 Mar 31, 2014: Cytomedix Announces Senior Management Appointments 119
7.1.3 Mar 18, 2014: Theragenics Appoints Mark Kesti as Vice President of Sales for Galt Medical and NeedleTech Products 120
7.1.4 Mar 01, 2014: Patient Satisfaction and Convenience Increased with Current Hereditary Angioedema Treatment Options, According to Study Findings 121
7.1.5 Nov 04, 2013: BioDerm Appoints Jim Terpstra as National Sales Manager 121
7.2 Financial Announcements 122
7.2.1 Aug 14, 2014: Cytomedix Reports Second Quarter 2014 Financial Results 122
7.2.2 Aug 07, 2014: Derma Sciences Reports Second Quarter Financial Results 123
7.2.3 Jul 24, 2014: Bard Announces Second Quarter Results 125
7.2.4 Jun 19, 2014: Novo Nordisk Announces U.S. Launch of New Insulin Device Levemir FlexTouch 126
7.2.5 May 15, 2014: Cytomedix Reports 2014 First Quarter Financial Results 128
7.2.6 May 08, 2014: Derma Sciences Reports First Quarter Financial Results 130
7.2.7 Apr 22, 2014: Bard Announces First Quarter Results 131
7.2.8 Mar 31, 2014: Cytomedix Reports 2013 Fourth Quarter and Full Year Financial Results 132
7.2.9 Mar 14, 2014: Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products 133
7.2.10 Jan 30, 2014: Bard Announces Fourth Quarter Results 135
7.2.11 Jan 16, 2014: Derma Sciences Announces Record Revenues for the 2013 Fourth Quarter and Full Year, Introduces 2014 Revenue Guidance 136
7.2.12 Dec 23, 2013: Titan Pharmaceuticals Receives Official Minutes From FDA Meeting on Probuphine New Drug Application 136
7.2.13 Dec 11, 2013: Bard Declares Quarterly Dividend 137
7.2.14 Nov 13, 2013: Derma Sciences Reports Third Quarter Financial Results 137
7.2.15 Nov 12, 2013: Cytomedix Reports Third Quarter 2013 Financial Results 138
7.2.16 Nov 06, 2013: Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 13th 141
7.2.17 Oct 22, 2013: Bard Announces Third Quarter Results 141
7.2.18 Oct 09, 2013: Bard Declares Quarterly Dividend 141
7.3 Government and Public Interest 141
7.3.1 Jan 06, 2014: Bard to Host Earnings Conference Call on January 30, 2014 141
7.3.2 Dec 20, 2013: Bard to Present at J.P. Morgan Healthcare Conference 142
7.3.3 Dec 04, 2013: Derma Sciences to Present at the Oppenheimer & Co. Inc. 24th Annual Healthcare Conference 142
7.3.4 Nov 25, 2013: Derma Sciences to Participate in the 25th Annual Piper Jaffray Healthcare Conference 142
7.3.5 Nov 20, 2013: Bard to Present at Piper Jaffray Healthcare Conference 142
7.3.6 Nov 12, 2013: Derma Sciences to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum 142
7.3.7 Oct 29, 2013: Bard to Present at Credit Suisse Healthcare Conference 142
7.4 Other Significant Developments 143
7.4.1 Apr 16, 2014: Bard Declares Quarterly Dividend 143
7.5 Product News 143
7.5.1 Jul 21, 2014: US Patent Office Grants McCord Research Endothelial Cell Treatment Patent 143
7.6 Strategy And Business Planning 143
7.6.1 Sep 30, 2014: CSL Behring Expands Manufacturing Facility in Kankakee, Illinois to Meet Patients Growing Needs 143
7.6.2 Aug 27, 2014: Theragenics Opens Manufacturing Plant in Costa Rica 144
7.6.3 Aug 20, 2014: Cytomedix Partners With Net Health to Expand CED Data Collection Capabilities to Approximately 400 Additional Wound Care Centers 144
8 Appendix 146
8.1 Research Methodology 147
8.1.1 Coverage 147
8.1.2 Secondary Research 147
8.1.3 Primary Research 148
8.1.4 Market Modeling and Forecasting 149
8.1.5 Company Share Analysis 152
8.1.6 Distribution Share Analysis 153
8.2 Expert Panel 153
8.3 GlobalData Consulting 154
8.4 Contact Us 154
8.5 Disclaimer 154
List Of Tables
1.1 List of Tables
Table 1: Wound Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 16
Table 2: Wound Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 18
Table 3: Hemostats Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 20
Table 4: Ligating Clips Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 22
Table 5: Surgical Adhesion Barriers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 23
Table 6: Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 25
Table 7: Manual Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 27
Table 8: Powered Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 29
Table 9: Tissue Adhesives Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 31
Table 10: Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 33
Table 11: Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 35
Table 12: Fibrin Based Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 37
Table 13: Hemostats Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 39
Table 14: Ligating Clips Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 41
Table 15: Surgical Adhesion Barriers Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 43
Table 16: Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 45
Table 17: Manual Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 47
Table 18: Powered Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 49
Table 19: Tissue Adhesives Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 51
Table 20: Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 53
Table 21: Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 55
Table 22: Fibrin Based Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 57
Table 23: Wound Closure Devices Market, United States, Volume (Units), Historic, 2005-2013 59
Table 24: Wound Closure Devices Market, United States, Volume (Units), Forecast, 2013-2020 61
Table 25: Hemostats Market, United States, Volume (Units), Historic, 2005-2013 63
Table 26: Ligating Clips Market, United States, Volume (Units), Historic, 2005-2013 65
Table 27: Surgical Adhesion Barriers Market, United States, Volume (Units), Historic, 2005-2013 66
Table 28: Surgical Stapling Devices Market, United States, Volume (Units), Historic, 2005-2013 68
Table 29: Manual Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013 70
Table 30: Powered Surgical Stapling Devices Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013 72
Table 31: Tissue Adhesives Market, United States, Volume (Units), Historic, 2005-2013 74
Table 32: Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013 76
Table 33: Non-Synthetic Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013 78
Table 34: Fibrin Based Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013 80
Table 35: Hemostats Market, United States, Volume (Units), Forecast, 2013-2020 82
Table 36: Ligating Clips Market, United States, Volume (Units), Forecast, 2013-2020 84
Table 37: Surgical Adhesion Barriers Market, United States, Volume (Units), Forecast, 2013-2020 86
Table 38: Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020 88
Table 39: Manual Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020 90
Table 40: Powered Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020 92
Table 41: Tissue Adhesives Market, United States, Volume (Units), Forecast, 2013-2020 94
Table 42: Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020 96
Table 43: Non-Synthetic Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020 98
Table 44: Fibrin Based Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020 100
Table 45: Wound Closure Devices Market, United States, Average Price ($), Historic, 2005-2013 101
Table 46: Wound Closure Devices Market, United States, Average Price ($), Forecast, 2013-2020 103
Table 47: Wound Closure Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2012-2013 105
Table 48: Wound Closure Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2012-2013 107
Table 49: Wound Closure Devices Market Pipeline Products 111
Table 50: Derma Sciences Completes Public Offering Of Shares For US$86.3 Million 112
Table 51: SafeStitch Medical Completes Private Placement Of Shares And Warrants For US$3 Million 114
Table 52: BioDerm to Raise USD4.8 Million in Venture Financing 115
Table 53: Surgimatix To Raise US$0.5 Million In Venture Financing 116
Table 54: MxBiodevices To Raise US$8 Million In Venture Financing 117
Table 55: MxBiodevices Raises US$0.2 Million In Venture Financing 118
Table 56: Total Number of Primary Research Participants, Wound Care Management, by Country 149
List Of Figures
1.2 List of Figures
Figure 1: Wound Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 15
Figure 2: Wound Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 17
Figure 3: Hemostats Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 19
Figure 4: Ligating Clips Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 21
Figure 5: Surgical Adhesion Barriers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 23
Figure 6: Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 24
Figure 7: Manual Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 26
Figure 8: Powered Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 28
Figure 9: Tissue Adhesives Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 30
Figure 10: Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 32
Figure 11: Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 34
Figure 12: Fibrin Based Tissue Sealants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 36
Figure 13: Hemostats Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 38
Figure 14: Ligating Clips Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 40
Figure 15: Surgical Adhesion Barriers Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 42
Figure 16: Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 44
Figure 17: Manual Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 46
Figure 18: Powered Surgical Stapling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 48
Figure 19: Tissue Adhesives Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 50
Figure 20: Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 52
Figure 21: Non-Synthetic Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 54
Figure 22: Fibrin Based Tissue Sealants Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 56
Figure 23: Wound Closure Devices Market, United States, Volume (Units), Historic, 2005-2013 58
Figure 24: Wound Closure Devices Market, United States, Volume (Units), Forecast, 2013-2020 60
Figure 25: Hemostats Market, United States, Volume (Units), Historic, 2005-2013 62
Figure 26: Ligating Clips Market, United States, Volume (Units), Historic, 2005-2013 64
Figure 27: Surgical Adhesion Barriers Market, United States, Volume (Units), Historic, 2005-2013 66
Figure 28: Surgical Stapling Devices Market, United States, Volume (Units), Historic, 2005-2013 67
Figure 29: Manual Surgical Stapling Devices Market, United States, Volume (Units), Historic, 2005-2013 69
Figure 30: Powered Surgical Stapling Devices Market, United States, Volume (Units), Historic, 2005-2013 71
Figure 31: Tissue Adhesives Market, United States, Volume (Units), Historic, 2005-2013 73
Figure 32: Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013 75
Figure 33: Non-Synthetic Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013 77
Figure 34: Fibrin Based Tissue Sealants Market, United States, Volume (Units), Historic, 2005-2013 79
Figure 35: Hemostats Market, United States, Volume (Units), Forecast, 2013-2020 81
Figure 36: Ligating Clips Market, United States, Volume (Units), Forecast, 2013-2020 83
Figure 37: Surgical Adhesion Barriers Market, United States, Volume (Units), Forecast, 2013-2020 85
Figure 38: Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020 87
Figure 39: Manual Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020 89
Figure 40: Powered Surgical Stapling Devices Market, United States, Volume (Units), Forecast, 2013-2020 91
Figure 41: Tissue Adhesives Market, United States, Volume (Units), Forecast, 2013-2020 93
Figure 42: Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020 95
Figure 43: Non-Synthetic Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020 97
Figure 44: Fibrin Based Tissue Sealants Market, United States, Volume (Units), Forecast, 2013-2020 99
Figure 45: Wound Closure Devices Market, United States, Company Share (%), 2013 106
Figure 46: GlobalData Epidemiology-Based Forecasting Model 151
Figure 47: GlobalData Capital Equipment-Based Forecasting Model 152
Figure 48: Primary Interviews by Participant Type (%) 153
